Compare Travere Therapeutics Inc. Common Stock (TVTX) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Travere Therapeutics Inc. Common Stock vs Wynn Resorts, Limited — how do they compare? Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B), while Wynn Resorts, Limited trades at $74 (market cap $7.79B). The key difference: Wynn Resorts, Limited is the larger of the two by market cap, and Wynn Resorts, Limited pays a 1.32% dividend while Travere Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Travere Therapeutics Inc. Common Stock for 0 Days and Wynn Resorts, Limited for 77 Days on average.
| TVTX | WYNN | |
|---|---|---|
Market Cap | $4.88B | $7.79B |
Volume | 1,668,577 | 1,551,566 |
Sector | Health | Consumer Cyclical |
52-Week High | $67.52 | $133.09 |
52-Week Low | $26.79 | $73.73 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $5.01B | $18.04B |
Dividend Yield | — | 1.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Wynn Resorts (WYNN) trades at $73.73, down 1.64% on the day, amid a bearish technical signal. The stock shows strong analyst support with a 64% buy rating and a consensus price target of $130.73, implying significant upside. Recent Q2 2026 earnings beat expectations, driven by Macau strength, though U.S. margins face pressure. The company maintains solid revenue growth, with 2026 revenue projected at $7.4B, but net cash flow remains negative due to high capital expenditures for expansion projects like Wynn Al Marjan.
The outlook for WYNN is cautiously optimistic, with Macau recovery and new project potential offering growth opportunities. However, risks include elevated debt levels, rising capex, and competitive pressures. Investors should weigh the substantial upside projected by analysts against execution risks and macroeconomic sensitivities affecting the gaming sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Travere Therapeutics Inc. Common Stock
Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
